Cisco's AI Forecast Raise Confirms Momentum, But Waiting Remains Prudent

What happened

Cisco's fiscal Q1 2027 revenue grew 24% year-over-year, and management raised its AI infrastructure revenue forecast from hyperscalers to $9 billion for the fiscal year, up sharply from the $4 billion AI revenue target set for fiscal 2026. This news confirms continued strong AI adoption, but the master report's thesis centered not just on AI, but on simultaneous improvement in Security growth and inventory normalization. The article does not mention Security revenue, which had been flat-to-down for three consecutive quarters through Q3 FY2026, nor does it address the elevated inventory level of $4.7 billion. With the stock trading at roughly 37 times earnings, the market has already priced in much of the AI upside, leaving little margin for any operational slippage. Consequently, while the AI forecast raise is a positive signal, it does not alter the WAIT rating because the other legs of the investment thesis have not yet been confirmed.

Implication

The raised AI forecast reinforces Cisco's position in AI infrastructure, but it addresses only the demand side of the story. The key risks remain the stagnant Security segment, which has shown no reported revenue growth for three straight quarters, and rising inventory that pressures gross margins and ties up working capital. Until Cisco demonstrates two consecutive quarters of Security growth above 5% and inventory levels dropping below $4.7 billion, the conditions for a rating upgrade are unmet. Current valuation already embeds optimistic AI conversion and leaves little room for error if hyperscaler orders become sporadic or competitive pressure from Arista and Broadcom intensifies. Therefore, existing holders should maintain positions but avoid adding, while new investors should wait for either a pullback toward $108 or clearer evidence of broad-based operational improvement.

Thesis delta

The new data reinforces the AI narrative but does not address the Security and inventory concerns that anchor the WAIT rating. The investment thesis is unchanged: buy only at lower prices or after clear evidence of Security reacceleration and margin stability. Current AI strength alone does not justify paying 37x earnings.